HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tumor promoter arsenite stimulates histone H3 phosphoacetylation of proto-oncogenes c-fos and c-jun chromatin in human diploid fibroblasts.

Abstract
Although epidemiological studies have long established that inorganic arsenic is a potent human carcinogen, the underlying mechanisms are still poorly understood. Recent studies suggest that inorganic arsenic may act as a tumor promoter by perturbing key signaling transduction pathways. We have shown previously that arsenite can potently activate the mitogen-activated protein kinase cascades and induce the expression of proliferation-associated genes, including proto-oncogenes c-jun and c-fos. In order to elucidate further the molecular mechanisms underlying its tumor-promoting properties, we investigated the signaling events involved in arsenite-mediated induction of c-fos and c-jun. We found that induction of both c-fos and c-jun by arsenite can be substantially inhibited by the MEK- selective inhibitor U0126, suggesting that the ERK pathway is critically involved in their up-regulation. Interestingly, arsenite dramatically induced the phosphorylation and acetylation of histone H3 preceding the induction of mRNAs encoding c-fos and c-jun. Finally, chromatin immunoprecipitation assays revealed that arsenite treatment markedly induced the phosphorylation/acetylation of histone H3 associated with the c-fos and c-jun genes through an ERK-dependent pathway. Our results strongly suggest that arsenic-triggered alterations in chromatin structure perturb specific gene transcription, including that of proto-oncogenes c-jun and c-fos, and may thereby contribute to the carcinogenic process.
AuthorsJi Li, Myriam Gorospe, Janice Barnes, Yusen Liu
JournalThe Journal of biological chemistry (J Biol Chem) Vol. 278 Issue 15 Pg. 13183-91 (Apr 11 2003) ISSN: 0021-9258 [Print] United States
PMID12547826 (Publication Type: Journal Article)
Chemical References
  • Arsenites
  • Butadienes
  • Carcinogens
  • Chromatin
  • DNA Primers
  • Enzyme Inhibitors
  • Histones
  • Nitriles
  • RNA, Messenger
  • U 0126
  • Phosphoserine
  • Ribosomal Protein S6 Kinases, 90-kDa
  • mitogen and stress-activated protein kinase 1
  • Mitogen-Activated Protein Kinases
  • p38 Mitogen-Activated Protein Kinases
  • arsenite
Topics
  • Acetylation
  • Arsenites (pharmacology)
  • Base Sequence
  • Butadienes (pharmacology)
  • Carcinogens (pharmacology)
  • Cell Cycle (drug effects)
  • Chromatin (drug effects, metabolism)
  • DNA Primers
  • Diploidy
  • Enzyme Inhibitors (pharmacology)
  • Fibroblasts (drug effects, metabolism)
  • Genes, fos
  • Genes, jun
  • Histones (metabolism)
  • Humans
  • Kinetics
  • Mitogen-Activated Protein Kinases (antagonists & inhibitors)
  • Nitriles (pharmacology)
  • Phosphorylation
  • Phosphoserine (metabolism)
  • Polymerase Chain Reaction
  • RNA, Messenger (genetics)
  • Ribosomal Protein S6 Kinases, 90-kDa (antagonists & inhibitors, metabolism)
  • Transcription, Genetic
  • p38 Mitogen-Activated Protein Kinases

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: